Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach
Context: Alzheimer’s disease (AD) is the most common form of dementia affecting the aged population and neuroinflammation is one of the most observed AD pathologies. NF-κB is the central regulator of inflammation and inhibitor κB kinase (IKK) is the converging point in NF-κB activation. Celastrol is...
Main Authors: | Karpagam Veerappan, Sathishkumar Natarajan, Purushoth Ethiraj, Umashankar Vetrivel, Shila Samuel |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2016.1241809 |
Similar Items
-
Alzheimer's disease: In silico study of rosemary diterpenes activities
by: Zakariae Abbaoui, et al.
Published: (2024-01-01) -
Synthesis, antibacterial evaluation, in silico ADMET and molecular docking studies of new N-acylhydrazone derivatives from acridone
by: Mohammed Aarjane, et al.
Published: (2020-07-01) -
In Silico Studies of Two Biphenyl Based Oxime Containing Ligands
by: Bülent Dede, et al.
Published: (2021-11-01) -
Mechanistic insights into the role of amyloid-β in innate immunity
by: Tatum Prosswimmer, et al.
Published: (2024-03-01) -
Identification of Potent Acetylcholinesterase Inhibitors as New Candidates for Alzheimer Disease via Virtual Screening, Molecular Docking, Dynamic Simulation, and Molecular Mechanics–Poisson–Boltzmann Surface Area Calculations
by: Hind Yassmine Chennai, et al.
Published: (2024-03-01)